biotech - products for cardiovascular repair, medical supplies and immunotherapy division
MC 64ish mill SP 25 cents
Turnaround story flushing out old management for new. World class products in cardiovascular regen area which is supposedly best in class. 'Code red' implemented around a year ago (fitting name in hindsight seeing how close the company came to going under) and this upcoming quarterly will really be a make or break to see if the new management has been able to either reduce costs or increase revenue. im quietly confident they can.
* quarterly due before end of month with a 'breakout month' in adapt sales being identified by management
* Royal Adelaide Hospital has opened finally and was indicated in last quarterly that would positively impact this quarterly due to delays holding up the sales.
im making this tip as i think it wouldnt be too hard to jump from 25-32ish cents on the back of a good quarterly and as insurance perhaps a bit of hype in the quarterly around this TAVR business could bump it a little too.
